Dr. Rugo on 20-Year Span of Breast Cancer Advancements | OncLive
Dr. Rugo on 20-Year Span of Breast Cancer Advancements | OncLive
2 months ago
onclive.com
Dr. Rugo on the Future of Angiogenesis in Breast Cancer | OncLive
Dr. Rugo on the Future of Angiogenesis in Breast Cancer | O…
Sep 9, 2011
onclive.com
Dr. Rugo on the Efficacy of Bevacizumab in Breast Cancer | OncLive
Dr. Rugo on the Efficacy of Bevacizumab in Breast Cancer | O…
Oct 17, 2011
onclive.com
Dr. Rugo on Antiangiogenic Therapies in Breast Cancer | OncLive
Dr. Rugo on Antiangiogenic Therapies in Breast Cancer | OncL…
Aug 28, 2012
onclive.com
Dr. Rugo on Ongoing Trials in HER2 Breast Cancer | OncLive
Dr. Rugo on Ongoing Trials in HER2 Breast Cancer | OncLive
Feb 7, 2018
onclive.com
Dr. Rugo on the Future of Extended Adjuvant Hormone Therapy for Breast Cancer | OncLive
Dr. Rugo on the Future of Extended Adjuvant Hormone Therapy for Br…
Aug 29, 2017
onclive.com
Dr. Rugo on PI3K and mTOR Inhibitors for Breast Cancer | OncLive
Dr. Rugo on PI3K and mTOR Inhibitors for Breast Cancer | Onc…
Aug 8, 2013
onclive.com
1:04
Hear Hope S. Rugo, MD present updated phase 1b/2 safety and effi…
132 views5 months ago
FacebookOncLive
1:29
Meet Dr. Hope S. Rugo, a true champion in the fight against brea…
1.3K views5 months ago
FacebookCity of Hope
Dr. Rugo on Findings of Oral Paclitaxel With Encequidar in Met…
Jan 8, 2020
onclive.com
Dr. Rugo on the Phase III SOPHIA Trial in HER2 Breast Cancer | Onc…
Jun 4, 2019
onclive.com
1:44
Dr Rugo on Elacestrant-Based Combinations in ER /HER2– Metas…
Dec 11, 2024
onclive.com
Dr. Rugo on Recent Updates With Immunotherapy in TNBC | OncLive
May 19, 2020
onclive.com
Dr. Rugo on Updated Data From the SOPHIA Trial in HER2 Metastatic …
Dec 14, 2019
onclive.com
Dr. Rugo on Proliferation as an Anti-Angiogenesis Marker | OncLive
Oct 5, 2011
onclive.com
Dr. Rugo on the Utility of Margetuximab in HER2+ Metastati…
1 month ago
onclive.com
Dr. Hope Rugo on the First-line Superiority of Paclitaxel for Advan…
959 viewsJun 5, 2012
YouTubeOncLive
Dr Rugo on the FDA Approval of Inavolisib Plus Palbociclib and Ful…
Oct 11, 2024
onclive.com
Dr. Rugo on Anti-Angiogenesis Therapy Response Predictors | On…
Sep 7, 2011
onclive.com
3:04
Dr. Rugo on 20-Year Span of Breast Cancer Advancements
906 viewsMar 9, 2019
YouTubeOncLive
35:27
Dr. Hope Rugo – ESMO 2022 – Exploring the latest trial data & ad…
868 viewsDec 21, 2022
YouTubeKarger Publishers
1:23
Dr. Rugo on Pathway Changes in Breast Cancer
83 viewsJul 25, 2013
YouTubeTargeted Oncology
1:37
Dr Rugo on the Evolution of ADCs in HR /HER2 and HER2-Low Breast C…
Mar 9, 2024
onclive.com
1:20
Dr. Rugo on Hormone Therapy for Patients With Breast Cancer
235 viewsNov 6, 2017
YouTubeOncLive
1:42
Dr. Rugo on Chemotherapy for Metastatic Breast Cancer
236 viewsMay 28, 2013
YouTubeOncLive
2:07
Dr. Rugo on the Advances in the Treatment of HER2-Positive Breas…
350 viewsJan 8, 2013
YouTubeTargeted Oncology
0:53
KEYNOTE-522 Demonstrates Potential for Immunotherapy in Tri…
528 viewsOct 31, 2019
YouTubeTargeted Oncology
0:55
Dr. Rugo on the Future of Extended Adjuvant Hormone Therapy for Br…
208 viewsAug 28, 2017
YouTubeOncLive
2:11
Dr. Hope Rugo on Comparative Effectiveness in the NSABP B-38 …
156 viewsDec 4, 2012
YouTubeTargeted Oncology
1:52
Dr. Rugo on SWISH Trial for HR-Positive Breast Cancer
325 viewsJul 18, 2016
YouTubeOncLive
See more videos
Static thumbnail place holder